Thank you for bringing the good news about Urolithin A. Iām ready to start taking it, and also, would a daily dose of 1000mg offer greater benefits?
Iām not sure thatās good news. Most trials are outside the inner circle so they are no significant changes.
In particular that shows again that there are mostly no significant clinical outcomes and only in-vitro ones.
2 Likes
However, there is no double-blind study on whether weekly administration of rapamycin, coupled with the uncertainty of weekly administration, prolongs human lifespan or improves certain inflammatory markers.
AnUser
#25
Didnāt the Mannick study at least show an improvement in immune function?
Yes, one phase 2 study did, for ResTORbio, but then the FDA changed the endpoints for the phase 3 trial and that trial the drug failed.
2 Likes
LukeMV
#27
5 Likes